Curcumin attenuates memory deficits and the impairment of cholinergic and purinergic signaling in rats chronically exposed to cadmium

Environmental Toxicology

Volumn 32, Issue 1, 2017, Pages 70-83

  da Costa, Pauline ^a   Gonçalves, Jamile F ^a   Baldissarelli, Jucimara ^a   Mann, Thaís R ^a   Abdalla, Fátima H ^a   Fiorenza, Amanda M ^a   da Rosa, Michelle M ^a   Carvalho, Fabiano B ^a   Gutierres, Jessié M ^a   de Andrade, Cinthia M ^a   Rubin, Maribel A ^a   Schetinger, Maria Rosa C ^a   Morsch, Vera M ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

acetylcholinesterase; Cd; curcumin; ectonucleotidases; lipid peroxidation; memory

Indexed keywords

BRAIN; CADMIUM; DATA STORAGE EQUIPMENT; LIPIDS; OXIDATION; RATS; SUBSTRATES;

ACETYLCHOLINESTERASE; CD; CURCUMIN; ECTONUCLEOTIDASES; LIPID PEROXIDATION;

CADMIUM COMPOUNDS;

5' NUCLEOTIDASE; ACETYLCHOLINESTERASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CADMIUM; CURCUMIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; PURINERGIC RECEPTOR;

BLOOD; BRAIN; CADMIUM; CELLS AND CELL COMPONENTS; CHEMICAL REACTION; CHEMICAL SUBSTANCE; DOSE-RESPONSE RELATIONSHIP; ECOTOXICOLOGY; ENZYME ACTIVITY; LIPID; MEMORY; PHYSIOLOGY; POLLUTION EXPOSURE; RODENT;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; HYPOTHALAMUS; LIPID PEROXIDATION; LOCOMOTION; LYMPHOCYTE; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME; ANIMAL; AVOIDANCE BEHAVIOR; CADMIUM POISONING; CHEMICALLY INDUCED; CHOLINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECTS; ELECTRIC SHOCK; ENZYMOLOGY; MEMORY DISORDERS; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; AVOIDANCE LEARNING; CADMIUM POISONING; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; LIPID PEROXIDATION; MALE; MEMORY DISORDERS; MOTOR ACTIVITY; PARASYMPATHETIC NERVOUS SYSTEM; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION; SYNAPTOSOMES;

EID: 84947997812     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.22213     Document Type: Article

References (67)

1. Abbasi MA, Ilyas M, Aziz-ur-Rehmana Sonia A, Shahwar D, Razab MA, Khan KM, Ashraf M, Afzal I Ambreen N. 2012. Curcumin and its derivatives: Moderate inhibitors of acetylcholinesterase, butyrylcholinesterase and trypsin. Sci Iran 19:1580–1583.
2. Abdalla FH, Cardoso AC, Pereira LB, Schmatz R, Gonçalves JF, Stefanello N, Fiorenza AM, Gutierres JM, Serres JDS, Zanini D, Pimentel VC, Vieira JM, Schetinger MRC, Morsch VM, Mazzanti CM. 2013. Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats. Mol Cell Biochem 381:1–8.
3. +- ATPase activities. Physiol Behav 135:152–167.
4. Agrawal R, Mishra B, Tyagi E, Nath C, Shukla R. 2010. Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacol Res 61:247–252.
5. Bishnoi M, Chopra K, Kulkarni SK. 2008. Protective effect of curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav 88:511–522.
6. Bonan CD, Roesler R, Pereira GS, Battastini AM, Izquierdo I, Sarkis JJ. 2000. Learning-specific decrease in synaptosomal ATP diphosphohydrolase activity from hippocampus and entorhinal cortex of adult rats. Brain Res 854:253–256.
7. Borges LP, Brandao R, Godoi B, Nogueira CW, Zeni G. 2008. Oral administration of diphenyl diselenide protects against cadmium-induced liver damage in rats. Chem Biol Interact 171(1):15–25.
8. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. 2006. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358–404.
9. Böyum A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl 97:77–89.
10. Bradford MM. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254.
11. Burnstock G. 2006. Purinergic signalling. Br J Pharmacol 147:172–181.
12. 2+-ATPase activities: Protection by l-cysteine. Basic Clin Pharmacol Toxicol 94:112–118.
13. Carageorgiou H, Tzotzes V, Sideris A, Zarros A, Tsakiris S. 2005. Cadmium effects on brain acetylcholinesterase activity and antioxidant status of adult rats: Modulation by zinc, calcium and L-cysteine co-administration. Basic Clin Pharmacol Toxicol 97:320–324.
14. Cooke SF, Bliss TV. 2006. Plasticity in the human central nervous system. Brain 129:1659–1673.
15. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. 2004. Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 98:266–275.
16. Das A, Dikshit M, Nath C. 2001. Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age. Life Sci 68:1545–1555.
17. Dong S, Shen HM, Ong CN. 2001. Cadmium-induced apoptosis and phenotypic changes in mouse thymocytes. Mol Cell Biochem 222:11–20.
18. El-Demerdash FM, Yousef MI, Kedwany FS, Baghdadi HH. 2004. Cadmium-induced changes in lipid peroxidation, blood hematology, biochemical parameters and semen quality of male rats: protective role of vitamin E and beta-carotene. Food Chem Toxicol 42(10):1563–1571.
19. El-Demerdash FM, Yousef MI, Radwan FM. 2009. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol 47:249–254.
20. Ellman GL, Courtney DK, Andres V, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
21. Fitzgerald BB, Costa LG. 1993. Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats. Fundam Appl Toxicol 20:210–216.
22. Gonçalves JF, Fiorenza AM, Spanevello RM, Mazzanti CM, Bochi GV, Antes FG, Stefanello N, Rubin MA, Dressler VL, Morsch VM, Schetinger MR. 2010. N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium. Chem Biol Interact 186(1):53–60.
23. Gonçalves JF, Duarte MMMF, Fiorenza AM, Spanevello RM, Mazzanti CM, Schmatz R, Bagatini MD, Antes FG, Costa P, Abdalla FH, Dressler VL, Morsch VM, Schetinger MRC. 2012a. Hematological indices and activity of NTPDase and cholinesterase enzymes in rats exposed to cadmium and treated with N-acetylcysteine. Biometals 25:1195–1206.
24. Gonçalves JF, Nicoloso FT, da Costa P, Farias JG, Carvalho FB, da Rosa MM, Gutierres JM, Abdalla FH, Pereira JS, Dias GR, Barbosa NB, Dressler VL, Rubin MA, Morsch VM, Schetinger MR. 2012b. Behavior and brain enzymatic changes after long-term intoxication with cadmium salt or contaminated potatoes. Food Chem Toxicol 50(10):3709–3718.
25. Gonçalves JF, Spanevello RM, Fiorenza AM, Mazzanti CM, Bagatini MD, Rosa CS, Becker LV, Costa P, Abdalla FH, Morsch VM, Schetinger MRC. 2013. NTPDase and 5′-nucleotidase activities from synaptosomes and platelets of rats exposed to cadmium and treated with N-acetylcysteine. Int J Devl Neurosci 31:69–74.
26. Gutierres JM, Carvalho FB, Schetinger MRC, Marisco P, Agostinho P, Rodrigues MV, Rubin MA, Schmatz R, Silva CR, Cognato GP, Farias JG, Signor C, Morsch VM, Mazzanti CM, Bogo M, Bonan CD, Spanevello RM. 2014. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type. Life Sci 96:7–17.
27. Gutierres JM, Carvalho FB, Schetinger MRC, Rodrigues MV, Schmatz R, Pimentel VC, Vieira JM, Rosa MM, Marisco P, Ribeiro DA, Leal C, Rubin MA, Mazzanti CM, Spanevello RM. 2012. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats. Life Sci 91:1221–1228.
28. Gutierres JM, Kaizer RR, Schmatz R, Mazzanti CM, Vieira JM, Rodrigues MV, Jaques J, Carvalho F, Zanini D, Morsch VM, Schetinger MR, Spanevello RM. 2012. α-Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a high-fat diet. Cell Biochem Funct 30:286–292.
29. Gutiérrez-Reyes EY, Albores A, Ríos C. 1998. Increase of striatal dopamine release by cadmium in nursing rats and its prevention by dexamethasone-induced metallothionein. Toxicology 131:145–154.
30. Heymann D, Reddington M, Kreutzberg GM. 1984. Subcellular localization of 5′-nucleotidase in rat brain. J Neurochem 43:263–273.
31. Jaques JAS, Rezer JFP, Ruchel JB, Becker LV, Rosa CS, Souza VCG, Luz SCA, Gutierres JM, Gonçalves JF, Morsch VM, Schetinger MRC, Leal DBR. 2011. Lung and blood lymphocytes NTPDase and acetylcholinesterase activity in cigarette smoke-exposed rats treated with curcumin. Biom Prev Nutr 1:109–115.
32. Jaques JAS, Rezer JFP, Carvalho FB, Rosa MM, Gutierres JM, Gonçalves JF, Schmatz R, Bairros AV, Mazzanti CM, Rubin MA, Schetinger MRC, Leal DBR. 2012. Curcumin protects against cigarette smoke-induced cognitive impairment and increased acetylcholinesterase activity in rats. Physiol Behav 106:664–669.
33. Järup L, Akesson A. 2009. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201–208.
34. Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. 1998. Health effects of cadmium exposure—A review of the literature and a risk estimate. Scan J Work Environ Health 42:1–52.
35. Jones MM, Cherian MG. 1990. The search for chelate antagonists for chronic cadmium intoxication. Toxicology 6:1–25.
36. Kuhad A, Chopra K. 2007. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol 576:34–42.
37. Kumar A, Dogra S, Prakash A. 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behav Brain Res 205:384–390.
38. Luchese C, Brandão R, Oliveira R, Nogueira CW, Santos FW. 2007. Efficacy of diphenyl diselenide against cerebral and pulmonary damage induced by cadmium in mice. Toxicol Lett 173:181–190.
39. Manca D, Ricard AC, Trottier B, Chevalier G. 1991. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67:303–323.
40. Méndez-Armenta M, Ríos C. 2007. Cadmium neurotoxicity. Environ Toxicol Pharmacol 23:350–358.
41. Mesulam MM, Guillozet A, Shaw P, Levey A. 2002. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110:627–639.
42. Nagy A, Delgado-Escueta AV. 1984. Rapid preparation of synaptosomes from mammalian brain using non-toxic isosmotic gradient material (Percoll). J Neurochem 43:1114–1123.
43. Nemmiche S, Chabane-Sari D, Guiraud P. 2007. Role of α-tocopherol in cadmium induced oxidative stress in Wistar rat's blood, liver and brain. Chem Biol Interact 170:221–230.
44. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358.
45. Pari L, Murugavel P. 2007. Diallyl tetrasulfide improves cadmium induced alterations of acetylcholinesterase, ATPases and oxidative stress in brain of rat. Toxicology 234:44–50.
46. Pathak N, Khandelwal S. 2009. Immunomodulatory role of piperine in cadmium induced thymic atrophy and splenomegaly. Environ Toxicol Pharmacol 28:52–60.
47. Rocha JBT, Emanuelli T, Pereira ME. 1993. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol Exp 53:431–437.
48. Rubin MA, Berlese DB, Stiegemeier JA, Volkweis MA, Oliveira DM, dos Santos TL, Fenili AC, Mello CF. 2004. Intra-amygdala administration of polyamines modulates fear conditioning in rats. J Neurosci 24:2328–2334.
49. Santos FW, Graça DL, Zeni G, Rocha JB, Weis SN, Favero AM, Nogueira CW. 2006. Sub-chronic administration of diphenyl diselenide potentiates cadmium-induced testicular damage in mice. Reprod Toxicol 22:546–550.
50. Santos FW, Zeni G, Rocha JB, Weis SN, Fachinetto JM, Favero AM, Nogueira CW. 2005. Diphenyl diselenide reverses cadmium-induced oxidative damage on mice tissues. Chem Biol Interact 151:159–165.
51. Saravanan G, Ponmurugan P. 2013. Attenuation of streptozotocin-induced alterations in acetylcholinesterase and antioxidant system by S-allylcysteine in rats. Food Biosci 4:31–37.
52. Schetinger MRC, Morsch VM, Bonan CD, Wyse AT. 2007. NTPDase and 5′-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 31:77–98.
53. Schetinger MRC, Porto NM, Moretto MB, Morsch VM, Da Rocha JB, Vieira V, Moro F, Neis RT, Bittencourt S, Bonacorso HG, Zanatta N. 2000. New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochem Res 25:949–955.
54. Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Corrêa M, Rosa MM, Rubin MA, Schetinger MRC, Morsch VM. 2009. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 610:42–48.
55. Sethi P, Jyoti A, Hussain E, Sharma D. 2009. Curcumin attenuates aluminium-induced functional neurotoxicity in rats. Pharmacol Biochem Behav 93:31–39.
56. Shaikh ZA, Zaman K, Tang W, Vu T. 1999. Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine. Toxicol Lett 104:137–142.
57. Soreq H, Seidman S. 2001. Acetylcholinesterase—new roles for an old actor. Nat Rev Neurosci 2:294–302.
58. Takeda A, Takefuta S, Ijiro H, Okada S, Oku N. 1999. Cd transport in rat brain. Brain Res Bull 49:453–459.
59. Thiermann H, Szinicz L, Eyer P, Zilker T, Worek F. 2005. Correlation between red blood cell acetylcholinesterase activity and neuromuscular transmission in organophosphate poisoning. Chem Biol Interact 157:345–347.
60. Tomazzoni MI, Negrelle RRB, Centa ML. 2006. Fitoterapia popular: a busca instrumental enquanto prática terapêutica. Texto Contexto Enferm Florianópolis 15:115–121.
61. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. 1999. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288:73–90.
62. Yadav RS, Chandravanshi LP, Shukla RK, Sankhwar ML, Ansari RW, Shukla PK, Pant AB, Khanna VK. 2011. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. NeuroToxicology 32:760–768.
63. Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, Khanna VK. 2009. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol 240:367–376.
64. Yargiçoglu P, Ağar A, Oğuz Y, Izgüt-Uysal VN, Sentürk UK, Oner G. 1997. The effect of developmental exposure to cadmium (Cd) on visual evoked potentials (VEPs) and lipid peroxidation. Neurotoxicol Teratol 19:213–219.
65. Zalups RK, Ahmad S. 2003. Molecular handling of cadmium in transporting epithelia. Toxicol Appl Pharmacol 186:163–188.
66. Zarros A, Kalopita K, Tsakiris S, Baillie GS. 2013. Can acetylcholinesterase activity be considered as a reliable biomarker for the assessment of cadmium-induced neurotoxicity? Food Chem Toxicol 56:406–410.
67. Zhao J, Zhao Y, Zheng W, Lu Y, Feng G, Yu S. 2008. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res 1229:224–232.